Gene: OTUD7A
Official Full Name: OTU deubiquitinase 7Aprovided by HGNC
Gene Summary: The protein encoded by this gene is a deubiquitinizing enzyme and possible tumor suppressor. The encoded protein acts on TNF receptor associated factor 6 (TRAF6) to control nuclear factor kappa B expression. However, this gene is downregulated by SNAIL1 in hepatocellular carcinoma cells, contributing to their progression and malignancy. [provided by RefSeq, Aug 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20205 | OTUD7A Knockout cell line (HEK293) | Human | OTUD7A | 1:3~1:6 | Negative | Online Inquiry |
OTUD7A Gene Knockout Cell Lines are specialized cellular models engineered to lack the expression of the OTUD7A gene, a crucial regulator in ubiquitin signaling pathways. These knockout cell lines serve as an invaluable tool for researchers studying the functional implications of OTUD7A in various biological processes, including protein degradation, DNA repair, and cellular signaling. The absence of OTUD7A allows for the elucidation of its role in disease mechanisms, particularly cancer and neurodegeneration, by providing a system to investigate changes in cellular behavior due to the loss of this gene.
The core function of these knockout cell lines lies in their ability to facilitate targeted research into the biological consequences of OTUD7A deficiency. By utilizing advanced CRISPR-Cas9 gene-editing technology to create these cell lines, researchers can assess the impact of OTUD7A loss on the ubiquitin-proteasome system and its downstream effects on cellular homeostasis. This innovative approach enables a thorough examination of gene function through phenotypic characterization, pathway analysis, and drug response studies in a controlled environment.
The scientific significance of OTUD7A Gene Knockout Cell Lines extends to various applications in both academic and clinical research settings. They are pivotal for understanding cancer molecular biology, where alterations in ubiquitination processes often lead to therapeutic resistance. Furthermore, these models can aid in the development of targeted therapies that restore normal function or compensate for OTUD7A loss, thereby offering new avenues for treatment of related disorders.
Compared to traditional cell lines, OTUD7A knockout variants provide a more precise model for studying gene function, as they eliminate confounding variables associated with residual gene expression. Combined with our proprietary validation processes ensuring robust performance and reliability, these cell lines stand out in the market.
For researchers and clinicians dedicated to understanding disease mechanisms or developing novel therapeutics, OTUD7A Gene Knockout Cell Lines represent an essential resource. Their versatility allows users to explore multiple facets of cellular biology, fostering advancements in both basic and translational research. Our company, with its focus on cutting-edge genetic engineering techniques and expertise in cellular models, is committed to providing high-quality biological products that empower the scientific community in their quest for discovery and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.